Indication
High Cardiovascular Risk
1 clinical trial
1 product
1 drug
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Adult Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive MedicationsStatus: Recruiting, Estimated PCD: 2025-03-20
Product
ZilebesiranDrug
Varlilumab